Precision oncology in EGFR positive non-small cell lung cancer: Breaking the 10-year barrier-a case report

Autores organización

• Luis Leonardo Rojas Beltran

  Autor

• 

  Andres Felipe Cardona Mendoza

  Autor

Autores

• Ordóñez-Reyes C.
• Ruiz-Patiño A.
• Arrieta O.
• Zatarain-Barrón L.
• Recondo G.
• Ricaurte L.

Grupos de investigación

• Grupo de Inmunología celular y molecular Universidad El Bosque (InmuBo)

  Investigador

  Maria Consuelo Romero Sanchez

Resumen

Resumen no disponible

Keywords

• afatinib; bevacizumab; carboplatin; cetuximab; chromogranin; epidermal growth factor receptor; erlotinib; etoposide; ibandronic acid; irinotecan; messenger RNA; osimertinib; paclitaxel; protein p53; adenocarcinoma; adult; Article; bone marrow biopsy; bone metastasis; cancer chemotherapy; cancer staging; case report; cell transdifferentiation; clinical article; conformal radiotherapy; deterioration; disease exacerbation; dry cough; female; Hispanic; histopathology; human; human tissue; intensity modulated radiation therapy; liquid biopsy; lung biopsy; lung lesion; lung nodule; middle aged; neuropathy; never smoker; non small cell lung cancer; overall survival; pain; primary tumor; priority journal; skin toxicity; stereotactic body radiation therapy; thoracoscopy; thorax pain; treatment response